chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hives on my right arm (not same arm as shot)/hives on right leg; This is a spontaneous report from a contactable consumer (patient). This 42-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: 1), as single dose via an unspecified route of administration, administered in left arm on 28Feb2021 16:30 as single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On 01Mar2021 15:00, patient developed hives on right arm (not same arm as shot) one day later.  Patient had covid test post vaccination as nasal Swab, on 01Mar2021 and result was negative. The clinical outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Fever ranging from 102-106.7 highest for several days vomit, migraine, stomach pain, dizziness, short of breath, running off. Sluggish.
Patient requested a flu vaccine at pharmacy.  Patient called us after the vaccine was given and told us he had previously got one at his physician.  A pharmacist called and notified the physician.  No known adverse affects reported.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021 at 2:59 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Apr-2021 at 2:59 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 48.86.  Concomitant products were not provided.  On 28-APR-2021, Excursion time was 09 AM. temperature was 33 respectively. total doses given for the day was 150, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 19-APR-2021, vial was moved to clinic on 28-APR-2021. 4 vials were sent to clinic. Vaccine BUD date was 19-MAY-2021. On 28-APR-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 33, 10 AM: 36, 11 AM: 40, 12 PM: 41, 1PM: 41, 2 PM: 39, 3 PM: 41 and 4 PM: 40.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Vaccine was given to an 11 year old, age was not verified by nurse before giving the injection
Pt recvd 2nd dose of vax 19MAR92 & on 14JUL92 lab eval revealed SGPT of 64; pt exp no clinical sx; f/u lab eval on 31JUL92 revealed SGPT of 51;
Headache; Low Grade Fever; Aches; This is a spontaneous report from a contactable consumer (parent). A 19-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date not reported), via an unspecified route of administration, on 17Mar2021 16:45 (at the age of 19-year-old), as dose 1, single, for COVID-19 immunisation. Medical history included COVID-19 from an unknown date to 05Feb2021. The patient's concomitant medications were not reported. The patient experienced headache, low grade fever and aches on an unspecified date in Mar2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
t103 AX @ 10PM Panadol given & temp didn't dec has been greater than 100 since injected; emesis x 2 @ 1030PM & 2AM 27AUG91; taking fluids @ this time; fever broke 24 hrs p/started & no other problems;
given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given doses after 30 days/doses that were stored longer than 30 days were administered to 30-40 indivuduals) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Moderna vaccines were stored under improper storage conditions due to loss of power for more than 30 days and were administered to 30-40 individuals and none of the vail had temperature excursion and all the doses administered were 1st, 2nd and 3rd doses and were administered through intramuscular. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: Follow-up received contains significant information updated list of patients who took expired vaccine and all details were provided.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On about 30-JUN-2014, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On about 28-JUL-2013, the patient was treated by a physician for the onset of a severe vesicular rash, which was diagnosed as severe herpes zoster. On or about 02-SEP-2014, the patient was treated by a physician for the onset of a severe vesicular rash, which was diagnosed as severe herpes zoster. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages on unspecified dates, and required extensive medical care and treatment. As a further proximate result, the patient had suffered and would continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.
REGULARLY DIZZY; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced regularly dizzy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from regularly dizzy. This report was non-serious.
11/9/2021 - HEADACHE CONTINUOUSLY AND SUNBURNED FEELING ON BOTTOM AND BACK OF THIGHS UNTIL PRESENT DATE  12/2/2021 -  MIGRAINE HEADACHE WITH DIZZINESS AND NAUSEA  FLU LIKE SYMTOMS ENDING WITH A POSITIVE COVID TEST  WITHIN ONE WEEK OF VACCINE
PATIENT WAS ADMINISTERD A MODERNA BIVALENT BOOSTER VACCINATION ON 10/18/22 BUT ONLY RECEIVED 0.3ML.  PATIENT WILL BE REVACCINATED WITH MODERNA BIVLAENT BOOSTER 0.5ML PER CDC INTERIM CLINICAL CONSIDERATION APPENDIX D  LOWER-THAN-AUTHORIZED DOSE ADMINISTERED.
side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.            No concomitant information was provided. Treatment information was not provided.
COPD, moderate. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
administered a dose of moderna to a patient that had been in the fridge, punctured greater than 12 hours.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered a dose of moderna to a patient that had been in the fridge, punctured greater than 12 hours.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered a dose of moderna to a patient that had been in the fridge, punctured greater than 12 hours.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered a dose of moderna to a patient that had been in the fridge, punctured greater than 12 hours.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
I had Pain in my right shoulder/tired but mostly wandering joint pain; foggy; tired but mostly wandering joint pain; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program. A patient of an unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration in arm left (reported as left shoulder) on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, patient experienced pain in right shoulder, even though had the shot in the left shoulder, since then patient had a variety of symptoms foggy, tired but mostly wandering joint pain. Patient described the condition was horrid and it's been three months can hardly lift a small pan full of water and stated this was from that vaccine. Patient had second Pfizer shot was 08Mar2021. The outcome of events was unknown.  Information about lot/batch number is requested.
Person called  to ask about COVID vaccines reactions. Is having tingling on one side of the body along with fever, fatigue, flushing, nausea, and a rash
Spontaneous urticaria started to present in scalp on 05/13/2022, itching all over subsequently, lethargic for 48 hours. Then saw a provider and received prednisone for 7 days 60mg orally daily. That held the itching down and then reoccurred after dosage. Cetrizine 10mg orally twice daily is now required to keep the inflammation down. Flares are upon waking and around 3pm if untreated.
Target lesions and raised papules symptomatic. Tx Atarax, Tylenol, Zantac, Orapred. Medical records state fever. msv
Approximately 10 minutes post vax, the pt complained of pain in left arm at injection site extending to the top of shoulders. Child was seen at the dentist immediately following injection. 45 minutes after returning home the child began crying due to pain at injection site. Child cried and wailed for  1 hour. Arm looked "normal" to parent with no redness or edema.
That after receiving the Covid vaccine in January that patient has been experiencing tinnitus; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number was not reported) via an unspecified route of administration on an unspecified date in Jan2021 as unknown, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced that after receiving the COVID-19 vaccine in January that patient has been experiencing tinnitus. Employee offered to take her information and turn it into Pfizer, employee did not wish to be reached by Pfizer as she suggested that she already informed the CDC. Patient had reported the events on her own. The clinical outcome of the experienced that after receiving the COVID-19 vaccine in January that patient has been experiencing tinnitus was unknown.  No follow up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a physician concerning an 18 year old female who on 04-JUN-2007 was vaccinated with the first dose of Gardasil (lot # 653736/0868F) injection.  There was no concomitant medication.  On 04-JUN-2007, the patient experienced a vasovagal reaction.  After receiving the vaccination, the patient sat for a while, and then when she got up, the patient started to get pale and light headed.  The patient laid down, was given fluids, and had her blood pressure taken.  After that the patient was fine and was able to leave.  Additional information has been requested.
still has dry mouth; metallic taste in his mouth; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRY MOUTH (non-serious), outcome "unknown", described as "still has dry mouth"; DYSGEUSIA (non-serious), outcome "unknown", described as "metallic taste in his mouth".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4 inch Swelling , heat mild soreness and itching at injection site starting a week after injection
A few hours after Rabies vaccine was given, had dizziness and headache. The next day had enlarged lymph nodes, fever of 100.0 F, extreme lethargy, body aches (worst in the back of the neck), Flu like sx, HA. Fever lasted for 3 days. Lethargyx 4, HA x 7 days. Nausea along with HA for on day. Refused 3rd Rabies shot that was due in 2 weeks. Still have HA for the last 7 days since the vaccine was given.
750 am gave vaccine (see below) approximately 20 mm later developed itching at localized left arm, mild redness.  BENADRYL 25 mg gave by mouth.  850 still itching, took BENADRYL 50mg by mouth (was not in clinic). 915 emesis face and armpits itching.  Went to emergency department treated monitored and released within 24 hours.  Returned to emergency department later that early following morning difficulty breathing-per patient treated and released.
Fever of 101.6. Nausea. Muscle soreness throughout entire body, especially left arm, neck, and back. Treated with Tylenol. Symptoms gone in approximately 18 hours.
I have had my urticaria in remission for 7 years.  By the morning after the injection, I had hives covering back qnd upper arms.  I took 10 Mil prednisone for 3 days and hives subsided.
sore arm 1:42 pm, severe headache 2:20 pm, heat on arm 2:25 pm, nausea 7 pm, fatigue 7pm
Extreme vertigo event lasting 3-4 hours. Extreme dizziness (spinning, intense vomiting, intense sweating). Went by ambulance to hospital and admitted as outpatient continuing observation. No health conditions found and symptoms subsided.
I experienced a lot of joint pain, swollen glands and hot flashes which lasted for about 6 weeks straight. It happened when I got my booster also but only lasted 3 weeks.
Pt. appeared to pass out - fell onto her face - some bleeding from mouth - no loose teeth. MOC stated daughter passes out after shots. MOC took daughter to medical provider to be assured all was okay with daughter.
pt recv vax & devel fever, lt hand became red & swollen & felt very painful;
Became dizzy, pale, diaphoretic and fainted within minutes of receiving injection.  Seizure like arm movements for 3-5 seconds after. Opened eyes right after seizure like movement.  Placed head between knees x5 minutes. Drank 2 glasses apple juice and ate crackers.  Then placed on stretcher to lie flat for 10 minutes. Gradually and incrementally raised HOB to sitting position. Pt remained without further dizziness.  VS remained stable throughout.  Pt states that she didn't eat breakfast.
a full body rash. Last night temp was 103.7 without drugs and 102.1 with drugs.  Headache, dizzy, Nausea.
later got the flu; Initial information was received on 27-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a patient.  This case involves Adult with unknown gender patient who later got the flu after being vaccinated with Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine (produced by unknown manufacturer) (with unknown strength, dose, route, administration site, lot number  and expiration date) for Prophylactic vaccination.  On an unknown date the patient later got the flu (influenza) 2 weeks following the administration of Influenza vaccine.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
Pt was seen in the emergency room and put on antibiotics but she had swelling and redness at site of injection.
The study subject is a 13-year-old female with a history of reactive airway disease and nasal allergies who received Fluzone through our school-based influenza vaccination program. The subject complained of a headache and a "closed throat" within a short time of receiving the influenza vaccine in the morning of August 28th. Physical examination revealed an alert and oriented child in no evidence of respiratory distress, and on auscultation she had clear breath sounds without wheezing. Emergency medical team (EMT) arrived at 13:25. The initial vital sign revealed a BP of 130/90, HR of 100 beats/minute and 98% oxygen saturation. She was moving air well but was unable to take deep breaths. She was given 50 mg of Benadryl (suspension) and had no difficulty swallowing. Urticaria developed on her face. She complained of shallow breathing, tongue hurting, chest pain and difficulty swallowing. The subject was placed on 10 l/minute of oxygen by face mask. EMS arrived at 13:35 and transferred the child via ambulance to the emergency department. At the time of transfer, the child was off oxygen and in no distress.   Final diagnosis: urticaria with possible angioedema.
This case was reported by a consumer and described the occurrence of dizziness in an 18-year-old female subject who was vaccinated with Boostrix for prophylaxis.  The reporter is the subject's mother. A physician or other health care professional has not verified this report. The subject had no adverse events following receipt of prior immunizations. Concurrent medications included Prozac and Clonazepam. On 23 August 2006, the subject received unspecified dose of Boostrix. On 23 August 2006 the subject then inadvertently received another dose of Boostrix in the arm. The recommended dose of Boostrix, the subject experienced dizziness, itching, and swelling injection site. The subject was seen at a physician's office. At the time of initial reporting, 09 January 2007, the events were ongoing and the consumer reported that," they are continuing to try to find out what is wrong with her."
2hrs p/vax devel fever, vomiting, had no appetite; would not drink;temp 104;was seen by MD 18OCT95 had temp of 104.5 in office
Tdap administered 12-28-12, 7 days later (L) upper arm swollen, tender to touch, redness and warmth spreading to (L) upper inner arm.
Nausea, headache, body aches, left arm numbness & arm twitching, fatigue, elevated pulse.
I administered the BOOSTRIX injection into the left deltoid muscle and immediatly after removing the needle from the site, blood projectile squirted out from the injection site and then a red raised circle formed around the perimeter of the injection site. The patient also reported that there was itchiness present around the injection site but nowhere else.
Hives 1 and half hour after flu shot given. Taken to er - Given Benadryl and prelone. Hives gone 2-3 hours after meds given